Provided by Tiger Fintech (Singapore) Pte. Ltd.

Can Fite Biofarma

1.09
-0.0600-5.22%
Pre-market: 1.090.00000.00%08:58 EDT
Volume:137.86K
Turnover:155.45K
Market Cap:14.01M
PE:-1.00
High:1.18
Open:1.16
Low:1.08
Close:1.15
Loading ...
Apr 14, 2025

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 06, 2024

Correspondence

Form CORRESP - Correspondence
Apr 05, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 28, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 03, 2024

Correspondence

Form CORRESP - Correspondence
Sep 11, 2023

Correspondence

Form CORRESP - Correspondence
Apr 21, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 30, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 10, 2023

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Feb 08, 2023

Correspondence

CORRESP [Cover] - Correspondence
Jan 31, 2023

Public Prospectus

F-1 - Registration statement for certain foreign private issuers
Mar 24, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 13, 2022

Correspondence

CORRESP [Cover] - Correspondence
Aug 26, 2021

Public Prospectus

Can-Fite BioPharma Ltd.
Aug 26, 2021

Public Prospectus

F-1 - Registration statement for certain foreign private issuers